ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Zynex Inc

Zynex Inc (ZYXI)

8.26
0.15
(1.85%)
Cerrado 23 Noviembre 3:00PM
8.27
0.01
(0.12%)
Fuera de horario: 6:59PM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
8.26
Postura de Compra
7.98
Postura de Venta
8.40
Volume Operado de la Acción
63,590
8.125 Rango del Día 8.30
7.15 Rango de 52 semanas 13.77
Capitalización de Mercado [m]
Precio Anterior
8.11
Precio de Apertura
8.17
Última hora de negociación
Volumen financiero
US$ 522,040
Precio Promedio Ponderado
8.2095
Volumen promedio (3 m)
104,784
Acciones en circulación
31,845,545
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
27.06
Beneficio por acción (BPA)
0.31
turnover
184.32M
Beneficio neto
9.73M

Acerca de Zynex Inc

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets me... Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. it also develops and markets medical devices for non-invasive cardiac monitoring, the products of which are under development. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave and others. Mostrar más

Sector
Electromedical Apparatus
Industria
Electromedical Apparatus
Sitio web
Sede
Carson City, Nevada, USA
Fundado
-
Zynex Inc is listed in the Electromedical Apparatus sector of the NASDAQ with ticker ZYXI. The last closing price for Zynex was US$8.11. Over the last year, Zynex shares have traded in a share price range of US$ 7.15 to US$ 13.77.

Zynex currently has 31,845,545 shares in issue. The market capitalisation of Zynex is US$258.27 million. Zynex has a price to earnings ratio (PE ratio) of 27.06.

ZYXI Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.182.227722772288.088.277.7655587.87608832CS
4-0.41-4.728950403698.679.427.71086598.65172098CS
120.22.481389578168.069.427.461047848.25015839CS
26-2.26-21.482889733810.5210.637.151306178.68883394CS
52-0.66-7.399103139018.9213.777.1518437810.25677542CS
156-6.26-43.112947658414.5217.254.972794379.35472322CS
260-0.81-8.930540242569.0729.72714.9739376813.64240024CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PDYNPalladyne AI Corporation
US$ 4.59
(129.50%)
83.07M
QMCOQuantum Corporation
US$ 9.11
(126.62%)
39.48M
NANano Labs Ltd
US$ 8.26
(89.02%)
2.03M
XCURExicure Inc
US$ 18.60
(71.27%)
4.59M
SKKSKK Holdings Limited
US$ 1.75
(59.09%)
107.47M
AMIXAutonomix Medical Inc
US$ 6.21
(-54.07%)
897.51k
CETXCemtrex Inc
US$ 0.1146
(-41.74%)
22.89M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
US$ 3.09
(-26.25%)
305.85k
ENSCEnsysce Biosciences Inc
US$ 0.4414
(-25.49%)
3.93M
ELABElevai Labs Inc
US$ 0.0201
(-0.50%)
415.87M
NVDANVIDIA Corporation
US$ 141.95
(-3.22%)
229.93M
SMCISuper Micro Computer Inc
US$ 33.15
(11.62%)
155.43M
VRPXVirpax Pharmaceuticals Inc
US$ 0.5501
(-6.72%)
154.17M
SOUNSoundHound AI Inc
US$ 8.24
(18.05%)
103.6M

ZYXI Discussion

Ver más
penn33c penn33c 10 meses hace
Closed at 11.76 looking great
👍️0
penn33c penn33c 1 año hace
What just another GREAT Quarter And they keep reducing the amount of shares out there with there buy back program
👍️0
penn33c penn33c 1 año hace
One of the best things you could do The shorts cant short if there are no shares out there
👍️0
BobbyAx3lrod BobbyAx3lrod 1 año hace
Is that a good thing?
👍️0
penn33c penn33c 1 año hace
They are buying back another 10 million dollars worth that will make 50 million dollars in buybacks in 2 years
👍️0
BobbyAx3lrod BobbyAx3lrod 1 año hace
Same thing i said. Idk whats going on.
👍️0
BobbyAx3lrod BobbyAx3lrod 1 año hace
Wtf is going on with this company man seriously?

In 1 month, -16.57% in losses. Something is up. Is it the CEO Thomas Sandgaard leadership? Please someone make it make sense!
👍️0
Harry Wickey Harry Wickey 1 año hace
WTF
👍️0
penn33c penn33c 1 año hace
Its an obvious scenario Trading at less than 2X revenue
👍️0
penn33c penn33c 1 año hace
On a rumor? Ha Ha
👍️0
sarbel sarbel 1 año hace
What's your source?
👍️0
penn33c penn33c 1 año hace
I keep hearing there going private!!! Have you gotten any info on this?
👍️0
Twinsoul Twinsoul 1 año hace
My first purchase was apx 20 years ago too. Quite a ride...
Good luck!
Unbelievable it is as cheap as it is right now.
👍️0
penn33c penn33c 1 año hace
I think i have owned some for 20 years or longer(don't quote me on time) I have bought as low as 10 cents Fun to watch Enjoy the ride
👍️0
Twinsoul Twinsoul 1 año hace
We will, IMHO
Great company, great future.
Buy now and smile later
👍️0
penn33c penn33c 1 año hace
How can we have these prices We should be like a 40 dollar stock as we speak
👍️0
Triple nickle Triple nickle 2 años hace
To 10.78 a share
👍️0
penn33c penn33c 2 años hace
Is anyone hearing rumors that Zynex is going private?
👍️0
penn33c penn33c 2 años hace
news is out
👍️0
penn33c penn33c 2 años hace
Year end numbers come out after hours!! Good luck to everyone
👍️0
penn33c penn33c 2 años hace
Merry Christmas does anyone think we will get a rally towards the end of the year?
👍️0
penn33c penn33c 2 años hace
i Like the 13.85 but I believe we still go higher from here Anyone heard anything on the blood volume monitor?
👍️0
penn33c penn33c 2 años hace
It looks like we are going to break out from here (hello naked shorts) This might be fun
👍️0
penn33c penn33c 2 años hace
If the naked shorts have to cover there bets it could get good REAL SOON
👍️0
rado rado 2 años hace
The bottom line is finally growing. And I think the market likes the fact that there is blood monitor showing momentum.
👍️0
rado rado 2 años hace
Zynex Announces Additional Share Buyback Program

ENGLEWOOD, Colo., Nov. 1, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that its board of directors approved a program to buy back $10.0 million of the Company's common stock. The program will commence on November 1, 2022 and is scheduled to terminate on October 31, 2023 or when the $10.0 million buyback limit is reached.

Zynex
Zynex
"We are committed to driving long-term value for our shareholders and believe that the current strength of our balance sheet presents a strategic opportunity for a third buyback program," said Thomas Sandgaard, founder, and CEO of Zynex. "We've repurchased $20 million of our common stock thus far in 2022 and an additional $10 million share buyback reiterates our commitment to creating value. We believe our consistent performance and ability to maintain profitability is not reflected in Zynex's market valuation and are initiating this buyback program as an attractive opportunity to deploy capital and return value to our shareholders."

Under the share buyback program, buybacks may be made from time-to-time in open market and negotiated purchases, effective immediately through the next twelve months. These buybacks will be made in compliance with the SEC's Rule 10b-18, subject to market conditions, available liquidity, cash flow, applicable legal requirements, and other factors. The specific prices, numbers of shares, and timing of purchase transactions will be determined by the Company from time to time in its sole discretion. This program does not obligate the Company to acquire any particular amount of common stock, and the program may be suspended or discontinued at any time, including in the event the Company would be deemed to be making an acquisition of its own shares under Rule 13e-3 of the Securities Exchange Act of 1934, as amended.

The Company expects to finance the purchases with existing cash balances, which is not expected to have a material impact on capital levels.

Zynex, Inc. had approximately 41.6 million shares issued and 37.5 million shares outstanding as of November 1, 2022.
👍️0
rado rado 2 años hace
Market likes the latest report.
👍️0
penn33c penn33c 2 años hace
Maybe shorts are getting nervous !!!!
👍️0
rado rado 2 años hace
ZYXI 9.73

I'm guessing the recent strength may be due to expectations over the new blood volume monitor.
👍️0
rado rado 2 años hace
9.31 +7% Nice move

Yahoo shows forward of 20.66

Which is kind of ridiculous. That net income will go down.
👍️0
rado rado 2 años hace
I'm not sure what the forward PE is. How are you getting 8?
👍️0
rado rado 2 años hace
Zynex Rev up 18% Net Income up 19%

ENGLEWOOD, Colo., July 28, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the second quarter ended June 30, 2022.

Second Quarter 2022 Highlights:

Revenue increased 18% year over year to $36.8 million

Net income increased 19% to $3.3 million; Diluted EPS of $0.08

Adjusted EBITDA increased 16% to $5.5 million

Completed initial $10 million share buyback and announced an additional program of $10 million

Recorded highest number of orders in Company history



Second Quarter 2022 Financial Results Summary:

For the second quarter, the Company reported net revenue of $36.8 million, an 18% increase over second quarter of 2021. Gross margins were 80% and net income was $3.3 million, a 19% increase from Q2 2021.

As of June 30, 2022, the Company had working capital of $51.8 million. Cash on hand was $26.9 million at the end of the second quarter.

President and CEO Commentary:

"In Q2, we posted another quarter of top line growth and increased profitability. Our reps are becoming highly efficient and revenue projections reflect our confidence in the sales force to produce exceptional results. The record orders we posted in second quarter will put us in a position to realize strong results in the second half of 2022," said Thomas Sandgaard, President and CEO. "Additionally, we completed an initial $10 million share buyback program and announced another $10 million program to signal our ability to drive shareholder value."

Third Quarter and Full Year 2022 Guidance:

Zynex is reaffirming its full year 2022 revenue estimates in the range of $150-$170 million and Adjusted EBITDA between $25-$35 million.

The estimated range for third quarter 2022 revenue is between $40-$43 million, an increase of approximately 20% from Q3 2021. Adjusted EBITDA for the third quarter 2022 is estimated to range between $7-$9 million.

Conference Call and Webcast Details:

Thursday, July 28, 2022 at 2:15 p.m. MT / 4:15 p.m. ET

To register and participate in the webcast, interested parties should click on the following link or dial in approximately 10-15 minutes prior to the webcast: https://app.webinar.net/mV4arKMJQLl

US Participant Dial In (TOLL FREE): 1-844-825-9790
International Participant Dial In: 1-412-317-5170
Canada Participant Dial In (TOLL FREE): 1-855-669-9657
👍️0
penn33c penn33c 2 años hace
Whats the forward P/E like 8?
👍️0
rado rado 2 años hace
ZYXI 6.92 (-21.98%) Well, that was short-lived. Maybe it was the buyback
👍️0
rado rado 2 años hace
Where do you hear that? I haven't heard that.
👍️0
rado rado 2 años hace
ZYXI (9.00 +18%) is having a good day today
👍️0
rado rado 2 años hace
ZYXI (9.00 +18%) is having a good day today
👍️0
penn33c penn33c 2 años hace
Im sending myself a note $8.10 is a nice close Friday
👍️0
penn33c penn33c 2 años hace
Looks like we are going higher from here What does everyone else think?
👍️0
penn33c penn33c 3 años hace
things to seem to be going well!!!! Going private?
👍️0
penn33c penn33c 3 años hace
What would happen to us >If they go private?
👍️0
penn33c penn33c 3 años hace
Anyone ever hear anything on company going private? I keep hearing some noise about it.?
👍️0
MysticChaCha MysticChaCha 3 años hace
My gut feeling for Zynex is that there is good news from this point onward. This company is expanding. The stock market in general is bullish, otherwise why is Warren Buffett on a buying spree. I think things for Zynex are good from here.
👍️0
penn33c penn33c 3 años hace
10 million dollar buyback This is looking great
👍️0
penn33c penn33c 3 años hace
Is anyone hearing rumors that Zynex is going private?
👍️0
penn33c penn33c 3 años hace
Twitter is anyone on that?

Friends tell me there talking about Zynex going Private

How bad would that hurt the shorts?

And what would be the price if that happened? My guess would be 25 bucks

👍️0
penn33c penn33c 3 años hace
Anyone seen any info on ZYNEX going private? I had a friend of mine ask me about it!!!
👍️0
penn33c penn33c 3 años hace
Simply Wall Street had a nice article today I found it on Yahoo Finance
👍️0
MysticChaCha MysticChaCha 3 años hace
UFO was right several months ago about Zynex retracing back around the $6.30 range.
👍️0
MysticChaCha MysticChaCha 3 años hace
I hope the Zynex uptrend continues too. I see a lot of news for Zynex expanding its facilities and its products.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock